Abstract:At present, there are no effective antifibrotic drugs for patients with chronic liver disease; hence, the development of antifibrotic therapies is urgently needed. Here, we performed an experimental and translational study to investigate the potential and underlying mechanism of quercetin treatment in liver fibrosis, mainly focusing on the impact of quercetin on macrophages activation and polarization. BALB/c mice were induced liver fibrosis by carbon tetrachloride (CCl4) for 8 weeks and concomitantly treated with quercetin (50 mg/kg) or vehicle by daily gavage. Liver inflammation, fibrosis, and hepatic stellate cells (HSCs) activation were examined. Moreover, massive macrophages accumulation, M1 macrophages and their related markers, such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and monocyte chemotactic protein-1 (MCP-1) in livers were analyzed. In vitro, we used Raw 264.7 cells to examine the effect of quercetin on M1-polarized macrophages activation. Our results showed that quercetin dramatically ameliorated liver inflammation, fibrosis, and inhibited HSCs activation. These results were attributed to the reductive recruitment of macrophages (F4/80+ and CD68+) into the liver in quercetin-treated fibrotic mice confirmed by immunostaining and expression levels of marker molecules. Importantly, quercetin strongly inhibited M1 polarization and M1-related inflammatory cytokines in fibrotic livers when compared with vehicle-treated mice. In vitro, studies further revealed that quercetin efficiently inhibited macrophages activation and M1 polarization, as well as decreased the mRNA expression of M1 macrophage markers such as TNF-α, IL-1β, IL-6, and nitric oxide synthase 2. Mechanistically, the inhibition of M1 macrophages by quercetin was associated with the decreased levels of Notch1 expression on macrophages both in vivo and in vitro. Taken together, our data indicated that quercetin attenuated CCl4-induced liver inflammation and fibrosis in mice through inhibiting macrophages infiltration and modulating M1 macrophages polarization via targeting Notch1 pathway. Hence, quercetin holds promise as potential therapeutic agent for human fibrotic liver disease.

"INTERLEUKIN-7 AS A POTENTIAL THERAPEUTIC TARGET FOR ALLEVIATING HEPATIC FIBROSIS IN A MICE MODEL INDUCED BY CARBON TETRACHLORIDE: IMPLICATIONS FOR FITNESS AND EXERCISE"

Sja-Let-7 Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in a Mouse Model via Col1α2

IL-8 exacerbates CCl4-induced liver fibrosis in human IL-8-expressing mice via the PI3K/Akt/HIF-1α pathway

Effects of Cytokines on Carbon Tetrachloride-Induced Hepatic Fibrogenesis in Rats

Efficacy of Activated Vitamin D3 Combined with Interferon-α in the Treatment of CCL4-induced Hepatic Fibrosis in Mice

Profibrogenic role of IL-15 through IL-15 receptor alpha-mediated trans-presentation in the carbon tetrachloride-induced liver fibrosis model

EXPRESSION OF BMP-7 IN HEPATIC TISSUE IN HEPATIC FIBROSIS RATS INDUCED BY CARBON TETRACHLORIDE

Chemokine CX3CL1 has potential anti-fibrosis effect in mouse liver fibrosis

Antifibrotic Effects of Interleukin-10 on Experimental Hepatic Fibrosis.

The Role of Interleukin-22 in Liver Regeneration after Partial Hepatectomy with Liver Fibrosis in Mice

Interleukin-22 regulating Kupffer cell polarization through STAT3/Erk/Akt crosstalk pathways to extenuate liver fibrosis

Preventive Effect of Isostrictiniin from Nymphaea Candida on Carbon Tetrachloride-Induced Hepatic Fibrosis in Mice

Protective effect of Idelalisib on carbon tetrachloride‐induced liver fibrosis via microRNA‐124‐3P/phosphatidylinositol‐3‐hydroxykinase signalling pathway

Targeting cIAPs attenuates CCl4-induced liver fibrosis by increasing MMP9 expression derived from neutrophils

Effect of mycophenolate mofetil alleviates carbon tetrachloride-induced liver fibrosis in mice

Impaired Balance of T Helper 17/T Regulatory Cells in Carbon Tetrachloride-Induced Liver Fibrosis in Mice

Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice

Quercetin Attenuates the Activation of Hepatic Stellate Cells and Liver Fibrosis in Mice Through Modulation of HMGB1-TLR2/4-NF-κB Signaling Pathways.

Changes and Significance of Cytokines and Ultrastructure of Experimental Hepatic Fibrosis in Rats

The Flavonoid Quercetin Ameliorates Liver Inflammation and Fibrosis by Regulating Hepatic Macrophages Activation and Polarization in Mice

Study on Effect and Mechanism of Xiaochaihu Decoction Ameliorating Hepatic Fibrosis